Co-Authors
This is a "connection" page, showing publications co-authored by Johan Neyts and Rana Abdelnabi.
Connection Strength
1.787
-
Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model. J Infect Dis. 2021 09 01; 224(5):749-753.
Score: 0.965
-
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters. EBioMedicine. 2021 Jun; 68:103403.
Score: 0.237
-
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model. Biochem Biophys Res Commun. 2021 05 28; 555:134-139.
Score: 0.234
-
Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
Score: 0.060
-
Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021 09; 597(7874):103-108.
Score: 0.060
-
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
Score: 0.060
-
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 04 29; 184(9):2332-2347.e16.
Score: 0.058
-
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26955-26965.
Score: 0.057
-
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 11 20; 370(6519):950-957.
Score: 0.057